To validate these findings, we conducted a Western blot analysis to examine the levels of p-JAK2/t-JAK2 and p-STAT3/t-STAT3 proteins—pivotal components of the signaling pathway—in hepatocellular carcinoma cells (Figure 6G,H and Figure S2I,J). This evidence concerns the gene JAK2 and hepatocellular carcinoma.